MyFinsight
Home
Blog
About
Short-term investments
$48,542K
(-49.19%↓ Y/Y)
Cash and cash
equivalents
$41,417K
(-1.14%↓ Y/Y)
Prepaid expenses and
other current assets
$1,534K
(55.11%↑ Y/Y)
Total property and
equipment
$8,354K
(8.78%↑ Y/Y)
Total current assets
$91,493K
(-33.90%↓ Y/Y)
Property and equipment,
net
$4,248K
(-16.25%↓ Y/Y)
Operating lease
right-of-use assets
$1,977K
(-35.22%↓ Y/Y)
Other assets
$1,179K
(-28.42%↓ Y/Y)
Restricted cash
$195K
(-2.99%↓ Y/Y)
Less accumulated
depreciation
$4,106K
(57.44%↑ Y/Y)
Total assets
$99,092K
(-37.51%↓ Y/Y)
Total liabilities and
stockholders' equity
$99,092K
(-37.51%↓ Y/Y)
Total stockholders'
equity
$86,665K
(-39.41%↓ Y/Y)
Total liabilities
$12,427K
(-20.06%↓ Y/Y)
Accumulated deficit
-$311,887K
(-31.23%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$33K
(-131.13%↓ Y/Y)
Additional paid-in capital
$398,543K
(4.72%↑ Y/Y)
Total current
liabilities
$11,447K
(-14.77%↓ Y/Y)
Operating lease
liabilities, non-current
$980K
(-53.66%↓ Y/Y)
Common stock, 0.001 par
value 500,000,000...
$42K
(35.48%↑ Y/Y)
Accrued expenses and
other current...
$9,451K
(-15.01%↓ Y/Y)
Operating lease
liabilities, current
$1,135K
(-1.13%↓ Y/Y)
Accounts payable
$861K
(-25.97%↓ Y/Y)
Back
Back
Balance Sheet
Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV)
source: myfinsight.com